Highlights and Quick Summary
Current P/B ratio of Biofrontera AG Sponsored ADR is 1.28 (as of December 31, 2021)
- P/B ratio for the quarter ending June 30, 2022 was 3.08 (a 49.11% increase compared to previous quarter)
- Year-over-year quarterly P/B ratio decreased by -61.81%
- Annual P/B ratio for 2021 was 1.28 (a -94.07% decrease from previous year)
- Annual P/B ratio for 2021 was 21.55 (a 9.74% increase from previous year)
- Annual P/B ratio for 2020 was 19.64 (a -3.43% decrease from previous year)
Visit stockrow.com/BFAGY
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical P/B ratio of Biofrontera AG Sponsored ADR
Most recent P/B ratioof BFAGY including historical data for past 10 years.Interactive Chart of P/B ratio of Biofrontera AG Sponsored ADR
Biofrontera AG Sponsored ADR P/B ratio for the past 10 Years (both Annual and Quarterly)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | – | – | 3.08 | 2.07 | – |
2021 | 1.28 | 8.07 | 7.0 | 4.69 | 1.28 |
2020 | 19.64 | 0.0 | 28.61 | 32.71 | 19.64 |
2019 | – | 20.33 | 17.64 | 18.61 | 20.33 |
2018 | – | – | – | 7.39 | 6.34 |
2017 | – | – | 16.54 | 16.54 | 16.54 |
2016 | 16.54 | – | – | – | 16.54 |
Business Profile of Biofrontera AG Sponsored ADR
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic